Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chong, S.-A.
1997.
Tardive dyskinesia and CYP2D6 polymorphism in Chinese.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
586.
Côté, Gilles
Lesage, Alain
Chawky, Nadia
and
Loyer, Michel
1997.
Clinical specificity of prison inmates with severe mental disorders.
British Journal of Psychiatry,
Vol. 170,
Issue. 6,
p.
571.
Bates, G. D. I.
van Woerkom, A. E.
Lopes, O.
Waring, R.
and
Klovrza, L.
1997.
Genetic polymorphism and drug-induced movement disorders.
British Journal of Psychiatry,
Vol. 170,
Issue. 5,
p.
485.
Sajjad, S. H. A.
1997.
CYP2D6 genotype and tardive dyskinesia.
British Journal of Psychiatry,
Vol. 170,
Issue. 6,
p.
580.
Dahl, Alv A.
L�wert, Anette
Asserson, Sigurd
Bjarking, Lennart
Berglund, Johan
Kristensen, Flemming
Norum, Dag
T�nseth, Sverre
Bayer, Lotte
and
M�hlum, Eli
1998.
Hydroxylation polymorphism of debrisoquine hydroxylase (CYP2D6) in patients with schizophrenia in Norway and Denmark.
Human Psychopharmacology: Clinical and Experimental,
Vol. 13,
Issue. 7,
p.
509.
Lane, Roger M.
1998.
SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment.
Journal of Psychopharmacology,
Vol. 12,
Issue. 2,
p.
192.
de Leon, Jose
Barnhill, John
Rogers, Thea
Boyle, Jenni
Chou, Wen-Hwei
and
Wedlund, Peter J.
1998.
Pilot Study of the Cytochrome P450-2D6 Genotype in a Psychiatric State Hospital.
American Journal of Psychiatry,
Vol. 155,
Issue. 9,
p.
1278.
Jolliet, Pascale
and
Bourin, Michel
1998.
Adaptation de la posologie des neuroleptiques.
Revue Française des Laboratoires,
Vol. 1998,
Issue. 304,
p.
85.
Goldstein, Burton J.
and
Goodnick, Paul J
1998.
Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics.
Journal of Psychopharmacology,
Vol. 12,
Issue. 4_suppl,
p.
55.
Ohmori, Osamu
Kojima, Hideki
Shinkai, Takahiro
Terao, Takeshi
Suzuki, Takashi
and
Abe, Kazuhiko
1999.
Genetic association analysis between CYP2D6*2 allele and tardive dyskinesia in schizophrenic patients.
Psychiatry Research,
Vol. 87,
Issue. 2-3,
p.
239.
Carvajal, Alfonso
and
Martín Arias, Luis H.
1999.
Vol. 22,
Issue. ,
p.
45.
Catalano, Marco
1999.
The Challenges of Psychopharmacogenetics.
The American Journal of Human Genetics,
Vol. 65,
Issue. 3,
p.
606.
Bates, G. O. L.
Lopes, O.
van Woerkom, A. E.
Klovrza, L.
and
Waring, R.
1999.
Tardive dyskinesia in psychosis: probing abnormal metabolism with promethazine.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 4,
p.
294.
Adityanjee
Aderibigbe, Yekeen A
Jampala, V.Chowdary
and
Mathews, Thomas
1999.
The current status of tardive dystonia.
Biological Psychiatry,
Vol. 45,
Issue. 6,
p.
715.
Cichon, Sven
N�then, Markus M.
Rietschel, Marcella
and
Propping, Peter
2000.
Pharmacogenetics of schizophrenia.
American Journal of Medical Genetics,
Vol. 97,
Issue. 1,
p.
98.
Topić, Elizabeta
Štefanović, Mario
Ivanišević, Ana Maria
Blazinić, Franciska
Čulav, Jadranka
and
Skočilić, Željko
2000.
CYP2D6 Genotyping in Patients on Psychoactive Drug Therapy.
cclm,
Vol. 38,
Issue. 9,
p.
921.
Uges, Donald R.A.
and
Conemans, Jean M.H.
2000.
Forensic Science.
Vol. 2,
Issue. ,
p.
229.
Aitchison,, Katherine J.
Jordan,, Barry D.
and
Sharma,, Tonmoy
2000.
THE RELEVANCE OF ETHNIC INFLUENCES ON PHARMACOGENETICS TO THE TREATMENT OF PSYCHOSIS.
Drug Metabolism and Drug Interactions,
Vol. 16,
Issue. 1,
p.
15.
Chong, Siow-Ann
Tan, Ene-Choo
Tan, Chay-Hoon
Mahendren, Rathi
Tay, Agnes Hou-Ngee
and
Chua, Hong-Choon
2000.
Tardive dyskinesia is not associated with the serotonin gene polymorphism (5-HTTLPR) in Chinese.
American Journal of Medical Genetics,
Vol. 96,
Issue. 6,
p.
712.
Chou, Wen Hwei
Yan, Feng-Xiang
de Leon, Jose
Barnhill, John
Rogers, Thea
Cronin, Maureen
Pho, Mylan
Xiao, Vivian
Ryder, Thomas B.
Liu, Wei Wei
Teiling, Clotilde
and
Wedlund, Peter J.
2000.
Extension of a Pilot Study: Impact From the Cytochrome P450 2D6 Polymorphism on Outcome and Costs Associated With Severe Mental Illness.
Journal of Clinical Psychopharmacology,
Vol. 20,
Issue. 2,
p.
246.
eLetters
No eLetters have been published for this article.